Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Orphan Medical's Antizol sNDA accepted for filing

Aug. 22, 2000

Zyban may reduce weight gain in smoking cessation

Aug. 16, 2000

Methoxsalen shown to reduce smoking by increasing the bioavailability of nicotine

July 31, 2000

U.K. launch announced for Zyban

July 24, 2000

Disulfiram plus buprenorphine curbs cocaine use in dual opioid/cocaine-dependent subjects

June 28, 2000

Ligand's new retinoid RAR antagonists useful for preventing RAR agonist side effects

June 16, 2000

Recent data on KT-5720 confirm its ability to reverse morphine tolerance

June 14, 2000

Study links stress and cortisol levels in infancy to alcohol consumption in adulthood

June 8, 2000

Series of heparin antagonist peptides described by Commonwealth Biotechnologies

June 7, 2000

Scientists at BASF design new thrombin muteins as antidotes to thrombin inhibitors

June 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...